Bibliotecas PUC-SP - Busca Integrada

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma

per Ravi Potluri, Sandip Ranjan, Hitesh Bhandari, Helen Johnson, Andriy Moshyk, Srividya Kotapati
Publicat a Experimental Hematology & Oncology (2019-07-01)

Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo

per Ravi Potluri, Amit Kumar, Valérie Oriol-mathieu, Thierry Van Effelterre, Laurent Metz, Hitesh Bhandari
Publicat a BMC Infectious Diseases (2022-10-01)

Correlation between pathologic complete response, event-free survival/disease-free survival and overall survival in neoadjuvant and/or adjuvant HR+/HER2-breast cancer

per Anagha Gogate, Sandip Ranjan, Amit Kumar, Hitesh Bhandari, Eros Papademetriou, Inkyu Kim, Ravi Potluri
Publicat a Frontiers in Oncology (2023-05-01)

Associations of sex on economic burden in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from medical and pharmacy claims data

per Michael Butzner, Sanika Amonkar, Meiling Chen, Eros Papademetriou, Ravi Potluri, Xing Liu, Theodore Abraham
Publicat a Frontiers in Cardiovascular Medicine (2025-04-01)

Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China

per Abela Mpobela Agnarson, Xiao Chun Wang, Ravi Potluri, Hitesh Bhandari, Amit Dhir, Chrispin Kambili, Laurent Metz
Publicat a BMC Infectious Diseases (2020-02-01)

Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis.

per Ravi Potluri, Amit Kumar, Vikalp Maheshwari, Charlie Smith, Valerie Oriol Mathieu, Kerstin Luhn, Benoit Callendret, Hitesh Bhandari
Publicat a PLoS ONE (2020-01-01)

Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation

per John C. Stendahl, Sounok Sen, Michael Butzner, Eros Papademetriou, Ravi Potluri, Xing Liu, Daniel Jacoby, James V. Freeman
Publicat a Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2025-09-01)

Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-...

per Vipul Jairath, Tim Raine, Thomas P Leahy, Ravi Potluri, Karolina Wosik, David Grube, Joseph C Cappelleri, Peter Hur, Lauren Bartolome
Publicat a Journal of Comparative Effectiveness Research (2025-03-01)

Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis

per Vipul Jairath, Tim Raine, Thomas P Leahy, Ravi Potluri, Karolina Wosik, David Gruben, Joseph C Cappelleri, Peter Hur, Lauren Bartolome
Publicat a Journal of Comparative Effectiveness Research (2025-02-01)

How well do clinical and demographic characteristics predict Patient Health Questionnaire‐9 scores among patients with treatment‐resistant major depressive disorder in a real‐world...

per Jennifer Voelker, Kruti Joshi, Ella Daly, Eros Papademetriou, David Rotter, John J. Sheehan, Harsh Kuvadia, Xing Liu, Anandaroop Dasgupta, Ravi Potluri
Publicat a Brain and Behavior (2021-02-01)

Risk of seizures in a population of women with BRCA-positive metastatic breast cancer from an electronic health record database in the United States

per Alexander Liede, Wendy Sebby, Ashok Kumar Reddy Miriyala, Ravi Potluri, Debasish Mazumder, Anirban Ghosh, Eros Papademetriou, Ryan Kilpatrick, Jerzy E. Tyczynski
Publicat a BMC Cancer (2023-01-01)

Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

per Rafael Fonseca, Saad Z. Usmani, Maneesha Mehra, Mary Slavcev, Jianming He, Sarah Cote, Annette Lam, Jon Ukropec, Eric M. Maiese, Sandhya Nair, Ravi Potluri, Peter M. Voorhees
Publicat a BMC Cancer (2020-11-01)

Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047

per Dirk Schadendorf, Evan J Lipson, Christopher D Lao, Hussein Tawbi, Paolo A Ascierto, David F McDermott, Michael B Atkins, Georgina V Long, F Stephen Hodi, Andriy Moshyk, Meredith M Regan, Jennell Palaia, Abraham Selvan, Ravi Potluri, Sandip Ranjan, Sandeep Bilthare
Publicat a Journal for ImmunoTherapy of Cancer (2025-09-01)

Real‐World Treatment Patterns and Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and 1–3 Prior Lines of Therapy: Optum Database

per Binod Dhakal, Hermann Einsele, Jordan M. Schecter, William Deraedt, Nikoletta Lendvai, Ana Slaughter, Carolina Lonardi, Sandhya Nair, Nirosha Elsem Varghese, Jianming He, Akshay Kharat, Seina Lee, Patricia Cost, Ravi Potluri, Mythili Koneru, Nitin Patel, Erika Florendo, Paula Rodriguez‐Otero, Kwee Yong
Publicat a Cancer Medicine (2025-08-01)